One Company May Hold the Key to Alzheimer’s Treatment
Turning loved ones into shells of their former selves with the side effects of dementia…
And in the end taking their life.
Nearly 6 million Americans suffer from Alzheimer’s as of 2020 a figure that may rise to 14 million by 2050 as life expectancy continues to increase.
Big pharmaceutical companies over the past decade have thrown billions of dollars into trying to get some sort of progress toward a cure for Alzheimer’s and dementia.
Names like Pfizer and Johnson & Johnson and countless public research institutions and universities have all tried their hand at a cure.